Clinical Study

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients

Figure 2

Flowchart of treatment of patients with >grade 3 liver injury. ALT, alanine aminotransferase; PD-1, programmed cell death 1; PD-L1, programmed cell death ligand 1; anti-CTLA-4, cytotoxic T-lymphocyte antigen 4; PSL, prednisolone; IFX, infliximab; MMF, mycophenolate mofetil.